Kanabo Group PLC Grant of Options (1890X)
31 Diciembre 2021 - 4:00AM
UK Regulatory
TIDMKNB
RNS Number : 1890X
Kanabo Group PLC
31 December 2021
Kanabo Group Plc
("Kanabo" or the "Company")
Grant of Options
Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis
company that focuses on developing and commercialising
cannabis-derived products for medical patients and wellness CBD
consumers announces the grant of options over a total of 3,150,000
shares to certain employees, including General Manager, Michal Ben
Moshe, pursuant to their terms of employment.
Name No. of Vested Option Vesting Period for non-vested
Options options Exercise options
as of Price
today
Michal
Ben Options shall vest in 12 equal
Moshe tranches every three months
) PDMR) 2,025,000 506,250 16.5p over a 3-year period.
---------- --------- ---------- -----------------------------------
Options shall vest over a
4-year period, with 25% vesting
at the end of the first 12-months
("the Initial Vesting") and
the remaining 75% vesting
in 12 equal tranches every
three months following the
Other employees 1,125,000 - 16.5p Initial Vesting.
---------- --------- ---------- -----------------------------------
For further information, please visit
http://www.kanabogroup.com/ or contact the following:
Kanabo Group Plc
Avihu Tamir, CEO Via Vox Markets
Peterhouse Capital Ltd
Eran Zucker (Financial Adviser) Tel: +44 (0)20 7469 0930
Lucy Williams / Charles Goodfellow (Corporate Broker) Tel: +44 (0)20 7469 0930
Vox Markets (Investor Relations)
Kat Perez KanaboGroup@voxmarkets.co.uk
About Kanabo Group Plc
Kanabo Group Plc is creating a new standard in the medical
cannabis industry to improve the well-being of millions of people
around the world by providing a better alternative to the smoking
of medicinal cannabis flowers. Kanabo, which was the first
medicinal cannabis company to IPO on London Stock Exchange, has a
focus on the distribution of cannabis-derived products for medical
patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality
cannabis extract formulas, innovative medical-grade vaporizers, and
various non-smoking consumption solutions. Kanabo sells a range of
medical cannabis products and wellness CBD products in the Primary
Markets, including its VapePod, which delivers a metered dose with
every inhalation.
The Notification of Dealing Form provided in accordance with the
requirements of the Market Abuse Regulation in relation to the
transaction listed above is set out below.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Michal Ben Moshe
--------------------------------------- --------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Manager
--------------------------------------- --------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------------------- --------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Kanabo Group Plc
--------------------------------------- --------------------------------
b) LEI 213800XPJFSNWJIYKN52
--------------------------------------- --------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------
a) Description of the Ordinary Shares
financial instrument,
type of instrument
Identification code GB00BYQCS703
b) Nature of the transaction Share Options
--------------------------------------- --------------------------------
c) Price(s) and volume(s)
------------- --------------
Price(s) Volume(s)
------------- --------------
16.5p 2,025,000
------------- --------------
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 24.10.2021
--------------------------------------- --------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------------- --------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHDKDBPCBDKCBN
(END) Dow Jones Newswires
December 31, 2021 05:00 ET (10:00 GMT)
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
